Market ResearchFebruary 9, 2021 What Oregon’s Measure 109 Means for Hopeful Entrepreneurs and Investors
PressFebruary 9, 2021 Tryp Therapeutics Plans Phase 2a Eating Disorder Clinical Trial with Dr. Jennifer Miller
PressFebruary 5, 2021 Mindset Files Multiple Final Patent Applications on Its Novel Psilocybin-Inspired Compounds
PressFebruary 3, 2021 Champignon Brands : New Rapid mood Screener (RMS) Screens for Manic Symptoms and Bipolar I Disorder Features to Address Unmet Clinical Need
PressFebruary 2, 2021 MindMed Streamlines Leadership with Further Emphasis on Integrating Psychedelic Drug Development with Digital Medicines and Therapeutics
PressFebruary 1, 2021 PharmaTher Signs Exclusive Worldwide License Agreement for Patented Microneedle Delivery Technology to Deliver Ketamine
PressJanuary 29, 2021 Ehave, Inc. Utilizes Artificial Intelligence and Machine Learning for Big Data Management in Mental Healthcare
PressJanuary 26, 2021 Field Trip Health Ltd. Announces Opening of Field Trip Health Center in Atlanta, GA, as it Continues Expansion in the US
PressJanuary 25, 2021 Champignon Brands’ Canadian Rapid Treatment Center of Excellence Opens First Community-Based Centre in Ottawa to Provide Ketamine Treatment for Adults With Depression
PressJanuary 20, 2021 MindMed Announces the Start of the First-Ever Clinical Trial Combining MDMA and LSD
PressJanuary 19, 2021 Better Plant Affiliate NeonMind Lists on the Frankfurt Stock Exchange (FSE: 6UF)
